Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: shingles

Herpes Zoster & Tofacitinib

Arthritis & Rheumatology  |  October 3, 2017

Shingles, also known as herpes zoster (HZ), is a common and sometimes debilitating disease that disproportionately affects elderly individuals and those who are immunocompromised. Patients with rheumatoid arthritis (RA) have a 1.5–2-fold higher risk of developing HZ compared with healthy adults. Treatment with some disease-modifying anti-rheumatic drugs (DMARDs) has been shown to increase this risk….

Filed under:Biologics/DMARDsDrug Updates Tagged with:herpes zosterTofacitinib

Herpes Zoster & the Risk of Stroke in Patients with Autoimmune Diseases

Arthritis & Rheumatology  |  January 31, 2017

Herpes zoster (HZ) infection, also known as shingles, is caused by reactivation of latent varicella-zoster virus infection generally acquired decades earlier. This study was designed to test the hypothesis that the incidence of stroke immediately following HZ infection is increased in patients with autoimmune diseases compared with the incidence of stroke at later time points. Results: In patients with autoimmune diseases, incident HZ was associated with as much as a twofold increased risk of stroke. Prompt antiviral therapy was associated with lower incidence of subsequent stroke…

Filed under:ConditionsResearch Rheum Tagged with:Arthritis & RheumatologyAutoimmune diseaseherpes zosterInfectionResearchshinglesstroke

Rheumatology Patient, Investigator Reflect on Advancements in Lupus, Rheumatoid Arthritis Treatments

From the College  |  November 16, 2016

In 1969, Martha Lovato passed away from renal failure due to complications of lupus. Martha was 18 years old and survived only two years following her diagnosis. At the time, Martha’s disease was still a mystery to many physicians and researchers. Her treatment options were limited. In fall 2004, after an unprecedented battle with shingles…

Filed under:ConditionsFrom the CollegeResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:Dr. Amit GoldingLupusMedicationpatient careRheumatoid arthritisRheumatology Research FoundationSLETreatmentYolanda Grundhoffer

Tips on Vaccinating Patients with Rheumatic Diseases

Thomas R. Collins  |  June 13, 2016

CHICAGO—In October of last year, a 52-year-old woman came to see Kevin Winthrop, MD, MPH, associate professor in infectious diseases, public health and preventive medicine at the Oregon Health & Sciences University. She had rheumatoid arthritis and was taking methotrexate and prednisone. She had had little change in her RA disease severity and was considering…

Filed under:ConditionsPractice Support Tagged with:2016 State-of-the-Art Clinical SymposiumFluherpes zosterpatient carepneumoniaRheumatic Diseaserheumatology

The Effect of Tofacitinib on Live Vaccine Responses

Richard Quinn  |  February 26, 2016

New research indicates that vaccination for the herpes zoster virus in patients with rheumatoid arthritis starting tofacitinib appears to be both safe and useful. Rheumatologists may want to check the patient’s pre-existing immunity status prior to administering the vaccine…

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis

Varicella Zoster Virus May Cause Giant Cell Arteritis

Lara C. Pullen, PhD  |  August 3, 2015

Researchers have recently discovered a connection between the varicella zoster virus infection, which causes chicken pox and shingles, and giant cell arteritis…

Filed under:ConditionsVasculitis Tagged with:Giant Cell Arteritisvaricella zoster virusVasculitisvasculopathy

Vaccines and Biologics: What Rheumatologists Need to Know

Kurt Ullman  |  December 1, 2014

How vaccines, medications and rheumatic disease-related effects on immune system interact

Filed under:Biologics/DMARDsDrug UpdatesResearch Rheum Tagged with:BiologicsImmune SysteminteractionResearchRheumatic DiseaserheumatologistrheumatologyrituximabUllmanvaccines

The Science of Chronic Itch

Shivani V. Tripathi, MD, & Brian S. Kim, MD, MTR  |  December 1, 2014

Inside the pathophysiology, clinical presentations of chronic pruritus

Filed under:ConditionsEducation & TrainingMyositisProfessional TopicsResearch Rheum Tagged with:chronic pruritusitchKimmyositispathophysiologypatient careResearchrheumatology

Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians

Kathy Holliman  |  September 1, 2014

Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines

Filed under:Biologics/DMARDsClinical Criteria/GuidelinesConditionsDrug Updates Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugGuidelinesHollimanimmunocompromisedMethotrexatepatient carerheumatologistSafetyvaccination

ACR Winter Rheumatology Symposium: Answers to Your Tough Questions about Rheumatic Disease Therapy

Kimberly Retzlaff  |  May 1, 2013

Panelists discuss vaccination, biologics and infection, methotrexate, cardiovascular risk, and serial immunoglobulin testing and imaging

Filed under:ConditionsMeeting Reports Tagged with:ACR Winter Rheumatology SymposiumBiologicsInfectionMethotrexateRheumatic Diseasevaccination

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences